International Flavors & Fragrances Cumulative Gross Losses and Impairments increased by 23.7% to $6.03B in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Cumulative Gross Losses and Impairments shows an upward trend with a 11.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase signals deteriorating value in the investment portfolio, potentially leading to future earnings charges.
This represents the total unrealized losses and impairment charges on investments that have not yet been reflected in ne...
Varies significantly based on the size and nature of a company's investment portfolio.
cumulative_gross_losses_and_impairments| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $4.87B | $4.87B | $6.03B |
| QoQ Change | — | +0.0% | +23.7% |
| YoY Change | — | +0.0% | +23.7% |
| Segment | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Nourish | — | — | $2.62B | $2.62B | $2.62B | $2.62B | $2.62B | $2.62B |
| Health & Biosciences | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B |
| Food Ingredients | — | — | — | — | — | — | — | $1.15B |
| Total | — | — | $4.87B | — | — | — | $4.87B | $6.03B |
Nourish was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.